Management will host an investor briefing at 4:30 p.m. ET to detail the company's fiscal progress in the heart, lung, and liver transplant sectors. Domestic participants can join the call by dialing (800) 715-9871, while international callers should use (646) 307-1963, citing access code 6054544. The company has also arranged for a live webcast, which will be accessible through the investor relations portal on its website for those unable to join via phone.
TransMedics Sets August 4 Date for Q2 2026 Earnings
TransMedics Group will disclose its financial performance for the second quarter of 2026 on August 4, following the close of regular market trading. The Andover-based medical technology firm, which specializes in organ transplant therapy, intends to discuss these results during a scheduled conference call later that afternoon.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!